tiprankstipranks
Trending News
More News >
ImmunoPrecise Antibodies (IPA)
NASDAQ:IPA
US Market
Advertisement

ImmunoPrecise Antibodies (IPA) Cash flow

Compare
353 Followers

ImmunoPrecise Antibodies Cash Flow

IPA's free cash flow for Q3 2025 was C$-1.31M. For the 2025 fiscal year, IPA's free cash flow was decreased by C$-1.57M and operating cash flow was C$-1.20M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
C$ -6.41MC$ -4.25MC$ -19.83MC$ -9.92MC$ -600.00K
Investing Cash Flow
C$ -799.00KC$ -1.56MC$ -1.97MC$ -5.21MC$ -2.46M
Financing Cash Flow
C$ 14.89MC$ 1.02MC$ -621.00KC$ 2.88MC$ 43.38M
End Cash Position
C$ 10.79MC$ 3.54MC$ 8.37MC$ 30.05MC$ 41.84M
Free Cash Flow
C$ -7.21MC$ -5.64MC$ -21.33MC$ -11.18MC$ -2.03M
Currency in CAD

ImmunoPrecise Antibodies Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis